Bioactivation of morphine in human liver

Isolation and identification of morphinone, a toxic metabolite

Takashi Todaka, Takashi Ishida, Hideki Kita, Shizuo Narimatsu, Shigeru Yamano

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Morphinone, identified in the bile of guinea pigs and rats given morphine, is a reactive electrophile and has the ability to bind to glutathione (GSH) and tissue macromolecules, leading to GSH depletion and cell damage. We previously demonstrated that the livers of various animal species are capable of forming morphinone from morphine. In this study, we examined whether the human liver can produce morphinone from morphine. HPLC analysis revealed that the incubation of morphine with the 9000xg supernatant of human liver in the presence of NAD(P) and 2-mercaptoethanol (ME) gave a peak corresponding to the synthetic morphinone-ME adduct (MO-ME), which is readily formed by a nonenzymatic reaction of morphinone with ME. The reaction product was isolated and was unambiguously identified as MO-ME using FAB-MS and NMR analyses in comparison with synthetic MO-ME. The conversion of morphine to morphinone required NAD(P), and NAD was a preferred cofactor over NADP. All the 9000xg supernatants from six human livers could produce morphinone at different rates, ranging from 30 to 120 nmol/g liver/30 min with NAD at pH 7.4. The enzyme activity responsible for the formation of morphinone from morphine was mainly localized in the microsomes. The microsomal enzyme activity was inhibited by steroids, lithocholic acid and indomethacin. Among these compounds, steroids with a 17β-hydroxyl group almost completely depressed morphinone formation. In conclusion, the metabolic pathway of morphine to morphinone, a toxic metabolite, in human was shown for the first time in in vitro experiments.

Original languageEnglish
Pages (from-to)1275-1280
Number of pages6
JournalBiological and Pharmaceutical Bulletin
Volume28
Issue number7
DOIs
Publication statusPublished - Jul 2005

Fingerprint

Poisons
Morphine
Liver
NAD
Mercaptoethanol
morphinone
Steroids
Lithocholic Acid
Enzymes
Microsomes
Metabolic Networks and Pathways
NADP
Bile
Indomethacin
Hydroxyl Radical
Glutathione
Guinea Pigs
High Pressure Liquid Chromatography

Keywords

  • Human liver
  • Metabolic activation
  • Morphine 6-dehydrogenase
  • Morphine metabolism
  • Morphinone

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Bioactivation of morphine in human liver : Isolation and identification of morphinone, a toxic metabolite. / Todaka, Takashi; Ishida, Takashi; Kita, Hideki; Narimatsu, Shizuo; Yamano, Shigeru.

In: Biological and Pharmaceutical Bulletin, Vol. 28, No. 7, 07.2005, p. 1275-1280.

Research output: Contribution to journalArticle

Todaka, Takashi ; Ishida, Takashi ; Kita, Hideki ; Narimatsu, Shizuo ; Yamano, Shigeru. / Bioactivation of morphine in human liver : Isolation and identification of morphinone, a toxic metabolite. In: Biological and Pharmaceutical Bulletin. 2005 ; Vol. 28, No. 7. pp. 1275-1280.
@article{3469383112f341edb84d6a5deb3e0324,
title = "Bioactivation of morphine in human liver: Isolation and identification of morphinone, a toxic metabolite",
abstract = "Morphinone, identified in the bile of guinea pigs and rats given morphine, is a reactive electrophile and has the ability to bind to glutathione (GSH) and tissue macromolecules, leading to GSH depletion and cell damage. We previously demonstrated that the livers of various animal species are capable of forming morphinone from morphine. In this study, we examined whether the human liver can produce morphinone from morphine. HPLC analysis revealed that the incubation of morphine with the 9000xg supernatant of human liver in the presence of NAD(P) and 2-mercaptoethanol (ME) gave a peak corresponding to the synthetic morphinone-ME adduct (MO-ME), which is readily formed by a nonenzymatic reaction of morphinone with ME. The reaction product was isolated and was unambiguously identified as MO-ME using FAB-MS and NMR analyses in comparison with synthetic MO-ME. The conversion of morphine to morphinone required NAD(P), and NAD was a preferred cofactor over NADP. All the 9000xg supernatants from six human livers could produce morphinone at different rates, ranging from 30 to 120 nmol/g liver/30 min with NAD at pH 7.4. The enzyme activity responsible for the formation of morphinone from morphine was mainly localized in the microsomes. The microsomal enzyme activity was inhibited by steroids, lithocholic acid and indomethacin. Among these compounds, steroids with a 17β-hydroxyl group almost completely depressed morphinone formation. In conclusion, the metabolic pathway of morphine to morphinone, a toxic metabolite, in human was shown for the first time in in vitro experiments.",
keywords = "Human liver, Metabolic activation, Morphine 6-dehydrogenase, Morphine metabolism, Morphinone",
author = "Takashi Todaka and Takashi Ishida and Hideki Kita and Shizuo Narimatsu and Shigeru Yamano",
year = "2005",
month = "7",
doi = "10.1248/bpb.28.1275",
language = "English",
volume = "28",
pages = "1275--1280",
journal = "Biological and Pharmaceutical Bulletin",
issn = "0918-6158",
publisher = "Pharmaceutical Society of Japan",
number = "7",

}

TY - JOUR

T1 - Bioactivation of morphine in human liver

T2 - Isolation and identification of morphinone, a toxic metabolite

AU - Todaka, Takashi

AU - Ishida, Takashi

AU - Kita, Hideki

AU - Narimatsu, Shizuo

AU - Yamano, Shigeru

PY - 2005/7

Y1 - 2005/7

N2 - Morphinone, identified in the bile of guinea pigs and rats given morphine, is a reactive electrophile and has the ability to bind to glutathione (GSH) and tissue macromolecules, leading to GSH depletion and cell damage. We previously demonstrated that the livers of various animal species are capable of forming morphinone from morphine. In this study, we examined whether the human liver can produce morphinone from morphine. HPLC analysis revealed that the incubation of morphine with the 9000xg supernatant of human liver in the presence of NAD(P) and 2-mercaptoethanol (ME) gave a peak corresponding to the synthetic morphinone-ME adduct (MO-ME), which is readily formed by a nonenzymatic reaction of morphinone with ME. The reaction product was isolated and was unambiguously identified as MO-ME using FAB-MS and NMR analyses in comparison with synthetic MO-ME. The conversion of morphine to morphinone required NAD(P), and NAD was a preferred cofactor over NADP. All the 9000xg supernatants from six human livers could produce morphinone at different rates, ranging from 30 to 120 nmol/g liver/30 min with NAD at pH 7.4. The enzyme activity responsible for the formation of morphinone from morphine was mainly localized in the microsomes. The microsomal enzyme activity was inhibited by steroids, lithocholic acid and indomethacin. Among these compounds, steroids with a 17β-hydroxyl group almost completely depressed morphinone formation. In conclusion, the metabolic pathway of morphine to morphinone, a toxic metabolite, in human was shown for the first time in in vitro experiments.

AB - Morphinone, identified in the bile of guinea pigs and rats given morphine, is a reactive electrophile and has the ability to bind to glutathione (GSH) and tissue macromolecules, leading to GSH depletion and cell damage. We previously demonstrated that the livers of various animal species are capable of forming morphinone from morphine. In this study, we examined whether the human liver can produce morphinone from morphine. HPLC analysis revealed that the incubation of morphine with the 9000xg supernatant of human liver in the presence of NAD(P) and 2-mercaptoethanol (ME) gave a peak corresponding to the synthetic morphinone-ME adduct (MO-ME), which is readily formed by a nonenzymatic reaction of morphinone with ME. The reaction product was isolated and was unambiguously identified as MO-ME using FAB-MS and NMR analyses in comparison with synthetic MO-ME. The conversion of morphine to morphinone required NAD(P), and NAD was a preferred cofactor over NADP. All the 9000xg supernatants from six human livers could produce morphinone at different rates, ranging from 30 to 120 nmol/g liver/30 min with NAD at pH 7.4. The enzyme activity responsible for the formation of morphinone from morphine was mainly localized in the microsomes. The microsomal enzyme activity was inhibited by steroids, lithocholic acid and indomethacin. Among these compounds, steroids with a 17β-hydroxyl group almost completely depressed morphinone formation. In conclusion, the metabolic pathway of morphine to morphinone, a toxic metabolite, in human was shown for the first time in in vitro experiments.

KW - Human liver

KW - Metabolic activation

KW - Morphine 6-dehydrogenase

KW - Morphine metabolism

KW - Morphinone

UR - http://www.scopus.com/inward/record.url?scp=24944505992&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24944505992&partnerID=8YFLogxK

U2 - 10.1248/bpb.28.1275

DO - 10.1248/bpb.28.1275

M3 - Article

VL - 28

SP - 1275

EP - 1280

JO - Biological and Pharmaceutical Bulletin

JF - Biological and Pharmaceutical Bulletin

SN - 0918-6158

IS - 7

ER -